摘要
背景:糖尿病足溃疡(DFUS)是糖尿病的一种慢性、不可治愈的并发症,给患者和医疗系统带来了沉重的负担。外周血管R病、糖尿病神经病变和细胞因子/趋化因子活性异常是加重严重程度和阻止伤口修复的主要因素。不像急性伤口,DFU冲击这对传统的创面敷料提出了实质性的挑战,要求开发新型的、先进的创面愈合方式。一般来说,理想的伤口敷料应该提供湿润的伤口。环境保护,防止二次感染,消除伤口渗出,促进组织再生。 目的:目前,许多传统的创面敷料被用于DFU的治疗,但缺乏绝对的、通用的选择。因此,本次审查的目的是总结讨论和批判性地讨论与聚合物基敷料的药物和治疗活性有关的可用证据,以治疗DFUS。 结果:壳聚糖(Cs)、透明质酸(HA)、纤维素、海藻酸钠、右旋糖酐、胶原蛋白、明胶、弹性蛋白、纤维蛋白、丝素等天然聚合物种类繁多。用于治疗DFU。这些聚合物已被用于水凝胶,薄膜,水胶体,泡沫,膜,支架,微粒和纳米颗粒的形式。而且伤口对各种相互修饰、半合成或合成聚合物的活性和临床适用性也进行了批判性的讨论。 结论:本文综述了聚合物基伤口敷料的最新进展,特别强调了先进的高分子生物材料、创新的治疗策略。和用于治疗DFU的交付方法。
关键词: 糖尿病足溃疡,非线性伤口愈合,传统敷料,天然和合成聚合物,有效的升级。
图形摘要
Current Drug Targets
Title:Recent Advances in Polymer-based Wound Dressings for the Treatment of Diabetic Foot Ulcer: An Overview of State-of-the-art
Volume: 19 Issue: 5
关键词: 糖尿病足溃疡,非线性伤口愈合,传统敷料,天然和合成聚合物,有效的升级。
摘要: Background: Diabetic foot ulcers (DFUs) are the chronic, non-healing complications of diabetic mellitus which compels a significant burden to the patients and the healthcare system. Peripheral vascular disease, diabetic neuropathy, and abnormal cellular and cytokine/chemokine activity are among the prime players which exacerbate the severity and prevent wound repair. Unlike acute wounds, DFUs impose a substantial challenge to the conventional wound dressings and demand the development of novel and advanced wound healing modalities. In general, an ideal wound dressing should provide a moist wound environment, offer protection from secondary infections, eliminate wound exudate and stimulate tissue regeneration.
Objective: To date, numerous conventional wound dressings are employed for the management of DFUs but there is a lack of absolute and versatile choice. The current review was therefore aimed to summarize and critically discuss the available evidences related to pharmaceutical and therapeutic viability of polymer-based dressings for the treatment of DFUs.
Results: A versatile range of naturally-originated polymers including chitosan (CS), hyaluronic acid (HA), cellulose, alginate, dextran, collagen, gelatin, elastin, fibrin and silk fibroin have been utilized for the treatment of DFUs. These polymers have been used in the form of hydrogels, films, hydrocolloids, foams, membranes, scaffolds, microparticles, and nanoparticles. Moreover, the wound healing viability and clinical applicability of various mutually modified, semi-synthetic or synthetic polymers have also been critically discussed.
Conclusion: In summary, this review enlightens the most recent developments in polymer-based wound dressings with special emphasis on advanced polymeric biomaterials, innovative therapeutic strategies and delivery approaches for the treatment of DFUs.
Export Options
About this article
Cite this article as:
Recent Advances in Polymer-based Wound Dressings for the Treatment of Diabetic Foot Ulcer: An Overview of State-of-the-art, Current Drug Targets 2018; 19 (5) . https://dx.doi.org/10.2174/1389450118666170704132523
DOI https://dx.doi.org/10.2174/1389450118666170704132523 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile
Current Pharmaceutical Design Pharmacokinetics-Pharmacology Disconnection of Herbal Medicines and its Potential Solutions with Cellular Pharmacokinetic-Pharmacodynamic Strategy
Current Drug Metabolism Role of Gap Junction Channel in the Development of Beat-to-Beat Action Potential Repolarization Variability and Arrhythmias
Current Pharmaceutical Design Multi-scale LBP and SVM Classification to Identify Diabetic Retinopathy in Lesions
Current Medical Imaging Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications
Current Protein & Peptide Science Treating Cancer and No-Cancer Pain in Older and Oldest Old Patients
Current Pharmaceutical Design The Metabolite Trimethylamine-N-Oxide is an Emergent Biomarker of Human Health
Current Medicinal Chemistry Synthesis, Structural Characterization and Docking Studies of Sulfamoyl- Phenyl Acid Esters as Dipeptidyl Peptidase-IV Inhibitors
Current Computer-Aided Drug Design Interactions Between Plasma Proteins and Naturally Occurring Polyphenols
Current Drug Metabolism Neurotoxicity of Insecticides
Current Medicinal Chemistry Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors
Current Neuropharmacology The Role of 5-HT1A Receptors in Research Strategy for Extensive Pain Treatment
Current Topics in Medicinal Chemistry An Overview of Valuable Scientific Models for Diabetes Mellitus
Current Diabetes Reviews Schiff Bases of Istain: Antiglycation Activity
Letters in Drug Design & Discovery Acute Toxicological and Histopathological Elucidation of <i>Rheum emodi</i> Rhizome Extract to Demonstrate Antidiabetic Activity in Alloxan-induced Diabetic Rats
Current Bioactive Compounds The Impact of Bariatric Surgery in Patients with Type-2 Diabetes Mellitus
Current Diabetes Reviews p38 MAPK: A Potential Target of Chronic Pain
Current Medicinal Chemistry Differential Retinal Protein Expressions During form Deprivation Myopia in Albino Guinea Pigs
Current Proteomics Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism RAGE Signaling in Cell Adhesion and Inflammation
Current Pediatric Reviews